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Abstract
Forkhead Box M1 (Foxm1) is a transcription factor essential for organ morphogenesis and development of various cancers.
Although complete deletion of Foxm1 in Foxm1
2/2 mice caused embryonic lethality due to severe abnormalities in multiple
organ systems, requirements for Foxm1 in cardiomyocytes remain to be determined. This study was designed to elucidate
the cardiomyocyte-autonomous role of Foxm1 signaling in heart development. We generated a new mouse model in which
Foxm1 was specifically deleted from cardiomyocytes (Nkx2.5-Cre/Foxm1
fl/f mice). Deletion of Foxm1 from cardiomyocytes
was sufficient to disrupt heart morphogenesis and induce embryonic lethality in late gestation. Nkx2.5-Cre/Foxm1
fl/fl hearts
were dilated with thinning of the ventricular walls and interventricular septum, as well as disorganization of the
myocardium which culminated in cardiac fibrosis and decreased capillary density. Cardiomyocyte proliferation was
diminished in Nkx2.5-Cre/Foxm1
fl/fl hearts owing to altered expression of multiple cell cycle regulatory genes, such as
Cdc25B, Cyclin B1, Plk-1, nMyc and p21
cip1. In addition, Foxm1 deficient hearts displayed reduced expression of CaMKIId,
Hey2 and myocardin, which are critical mediators of cardiac function and myocardial growth. Our results indicate that
Foxm1 expression in cardiomyocytes is critical for proper heart development and required for cardiomyocyte proliferation
and myocardial growth.
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Introduction
The heart is the first organ to function during embryonic
development, the beating heart can be detected as early as
embryonic day 8 (E8) in the mouse [1,2]. Proper cardiac
development requires strict adherence to a temporal and spatial
pattern of gene expression. Embryonic development of the heart is
mediated by proliferative growth, with cardiomyocytes rapidly
progressing through the cell cycle and multiplying [3]. In the
postnatal period, cardiomyocytes withdrawal from the cell cycle
and cardiac growth becomes dependent on hypertrophy of
individual cardiomyocytes [3]. Transcriptional regulation of
cardiomyocyte proliferation during embryogenesis has been
extensively studied, and several cardiac transcription factors were
found to be critical for cardiomyocyte progression into the cell
cycle. These include GATA family members 4 and 6 [4],
myocardin [5], Twist family members 1 [6] and 2 [7], Hey2
[8,9], Sox4 [10] and Nkx2.5 [11].
Foxm1 (previously known as HFH-11B, Trident, Win, or
MPP2) is a member of the Forkhead Box (Fox) family of
transcription factors which share homology in the Winged
Helix/Forkhead DNA binding domain. Foxm1 is expressed in
proliferating cells of all embryonic tissues, including cardiac
progenitor cells and the early myocardium [12,13]. However,
expression wanes postnatally and Foxm1 can only be detected in a
few adult tissues such as intestinal crypts, thymus and testis
[14,15]. Foxm1 signaling has been shown to be a critical mediator
of both G1-S and G2-M transitions of the cell cycle, and to be
upregulated in various human cancers [16,17,18,19,20,21]. In
addition, Foxm1 was determined to play a role in tissue repair
following injury in the lungs and liver [15,22,23].
Foxm1-null (Foxm1
2/2) mouse lines have been previously
generated and characterized by two separate labs [24,25].
Foxm1
2/2 mice in which the DNA binding and C-terminal
transcriptional activation domains of the Foxm1 protein were
deleted die in utero between E13.5 and E16.5 due to multiple
abnormalities in various organ systems, including liver, lungs,
blood vessels, brain and heart [13,25,26,27]. Although these
studies showed that Foxm1 plays a cell autonomous role for organ
development in multiple cell types, the role of Foxm1 in cardiac
development and function remains unknown. Given widespread
organ defects in Foxm1
2/2 mice, it remains unclear whether
Foxm1 is critical for heart development or if cardiac abnormalities
are secondary to defects in other organ systems which could alter
embryonic growth. Therefore, a direct role of Foxm1 in
cardiomyocyte growth and/or function awaits elucidation.
As Foxm1 is widely expressed during embryogenesis [12,28,29],
the recent focus has been to elucidate the cell-specific roles of
Foxm1 in different tissues using conditional knockout mouse
models. Specific deletion of Foxm1 from hepatoblasts resulted in
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cords and vasculature, as well as a lack of intrahepatic bile ducts
[25]. Deletion of Foxm1 from precursors of cerebellar granule
neurons interfered with Shh-induced signaling to delay brain
development [30]. Foxm1 deletion from T lymphocyte lineage
decreased proliferation of early thymocytes and activated mature
T cells without affecting apoptosis or T cell differentiation [31].
However, mice with endothelial- or macrophage-specific Foxm1
deletions developed normally [32,33], indicating Foxm1 is
dispensable in these cells lines during embryogenesis. Further-
more, while deletion of Foxm1 specifically from the pancreas did
not affect pancreatic development [34], male mice developed islet
dysfunction and diabetes resulting from impaired postnatal b-cell
mass expansion [34] and females were prone to gestational
diabetes [35], indicating Foxm1 requirements differ during
pancreatic development. Deletion of Foxm1 specifically from
smooth muscle cells did not affect differentiation, but mice died
immediately after birth from severe pulmonary hemorrhage,
structural defects in the arterial wall and esophageal abnormalities
[28]. When Foxm1 was deleted conditionally in developing
respiratory epithelium proliferation rates of respiratory epithelial
cells were unaltered [12], suggesting that Foxm1 is not required for
epithelial proliferation during lung development. However,
deletion of Foxm1 from respiratory epithelium impaired lung
maturation, decreased expression of surfactant-associated proteins
SPA, SPB and SPC and delayed differentiation of type I cells from
epithelial precursors causing respiratory failure after birth [12].
Thus, Foxm1 is essential for surfactant homeostasis and lung
maturation during lung development. Studies in conditional
Foxm1 knockout models have shown that Foxm1 plays unique
roles in different tissues during embryonic development; the
cardiomyocyte-specific role of Foxm1 in heart development
remains unexplored.
In this study, we utilized the Cre-LoxP system to conditionally
delete Foxm1 from cardiomyocytes to ascertain the cardiomyo-
cyte-autonomous role of Foxm1 in heart development. Deletion of
Foxm1 from cardiomyocytes resulted in chamber dilation and
myocardial thinning, culminating in embryonic lethality in late
gestation. Cardiac Foxm1 deletion caused decreased cardiomyo-
cyte proliferation and altered expression of cell cycle regulators
Cdc25B, Cyclin B1, nMyc, Plk-1 and p21
cip1. We also identified
CaMKIId, Hey2 and myocardin as new potential targets of
Foxm1 signaling and mediators of myocardial thinning. This study
shows that Foxm1 is critical for expression of cell cycle regulatory
genes in developing cardiomyocytes and is required for proper
heart development.
Methods
Foxm1 conditional knockout mice
We have previously described the generation of Foxm1 LoxP/
LoxP (Foxm1
fl/fl) mice, in which LoxP sequences flank exons 4
through 7 of the Foxm1 gene encoding the DNA binding and
transcriptional activation domains [25]. Foxm1
fl/fl mice were bred
with Nkx2.5-Cre mice [36] to generate Nkx2.5-Cre/Foxm1
fl/fl double
transgenic mice with deletion of Foxm1 from the myocardium.
Using lineage tracing experiments previous studies demonstrated
that Nkx2.5-Cre was expressed in the early myocardium as well as
epithelium of the first pharyngeal arch [36]. However, no gross
morphological abnormalities were observed in any non-cardiac
tissues examined including thyroid and thymus (data not shown).
Nkx2.5-Cre/Foxm1
fl/fl homozygous embryos exhibited an embry-
onic lethal phenotype with the exception of one mouse from an
early breeding which survived to postnatal day 11 (P11). To
generate Nkx2.5-Cre/Foxm1
fl/fl embryos, Nkx2.5-Cre/Foxm1
fl/+ het-
erozygous males were bred with Foxm1
fl/fl females. Foxm1
fl/fl or
Nkx2.5-Cre/Foxm1
fl/+ embryos from the same litter were used as
controls. Animal studies were reviewed and approved by the
Animal Care and Use Committee of Cincinnati Children’s
Hospital Research Foundation.
Immunohistochemical staining
Nkx2.5-Cre/Foxm1
fl/fl and control embryos were harvested on
embryonic day 14.5 (E14.5) and E17.5. Embryos were then fixed
in 4% paraformaldehyde overnight and embedded into paraffin
blocks. Paraffin sections of 5 mm were used for immunohisto-
chemistry of specific proteins, stained with hematoxylin and eosin
(H&E) to evaluate cardiac morphology or stained with Masson’s
Trichrome to detect cardiac fibrosis. Antibodies used in immuno-
histochemical analysis were: Foxm1 (1:5000; k-19; Santa Cruz),
phospho-histone H3 (PH3; 1:5000; Santa Cruz), a-smooth muscle
actin (aSM; 1:10,000; Sigma-Aldrich), Ki-67 (1:10,000; Dako) and
PECAM-1 (1:10,000; Pharminogen). Antibody-antigen complexes
were detected using biotinylated secondary antibody followed by
avidin-HRP complex and DAB substrate (Vector Labs, Burlin-
game, CA) as previously described [12,13,26]. Sections were then
counterstained with nuclear fast red. For colocalization experi-
ments, slides were stained with a-actinin (1:100; Sigma-Aldrich)
Table 1. TaqMan gene expression assays (Applied
Biosystems) used for qRT-PCR analysis.
Mouse Foxm1 Mm00514924_m1
Mouse Cdc25B Mm00499136_m1
Mouse Cyclin B1 Mm00838401_g1
Mouse Cyclin D1 Mm00432359_m1
Mouse p21
cip1 Mm01303209_m1
Mouse Plk-1 Mm00440924_g1
Mouse cMyc Mm00487804_m1
Mouse nMyc Mm00476449_m1
Mouse CaMKIId Mm00499266_m1
Mouse b-catenin Mm00437992_m1
Mouse NFATc3 Mm01249200_m1
Mouse GATA4 Mm00484689_m1
Mouse GATA6 Mm00802636_m1
Mouse Hey2 Mm00469280_m1
Mouse Myocardin Mm00455051_m1
Mouse Twist1 Mm00442036_m1
Mouse Twist2 Mm00492147_m1
Mouse Sox4 Mm00486320_s1
Mouse Notch1 Mm00435245_m1
Mouse Notch2 Mm00440536_g1
Mouse FGF10 Mm00433275_m1
Mouse IL-1b Mm01336189_m1
Mouse TGF-b1 Mm03024053_m1
Mouse BMP2 Mm01340178_m1
Mouse BMP4 Mm01321704_m1
Mouse Wnt5a Mm00437347_m1
Mouse Wnt7b Mm00437357_m1
Mouse b-actin Mm00607939_s1
doi:10.1371/journal.pone.0022217.t001
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DAPI to detect nuclei (Vector Labs). Slides were photographed
using a Zeiss Axioplan2 microscope and Axiovision Rel 4.7
software.
Quantitative real-time RT-PCR (qRT-PCR)
Total cardiac RNA was prepared from individual Nkx2.5-Cre/
Foxm1
fl/fl and control hearts using RNA-STAT-60 (Tel-Test ‘‘B’’
Inc. Friendswood, TX). cDNA was generated using the Applied
Biosystems High Capacity cDNA Reverse Transcription kit
(Applied Biosystems, Foster City, CA). Evaluation of expression
levels of specific genes was performed by qRT-PCR using Taqman
probes(Table 1) and StepOnePlus Real-TimePCR system (Applied
Biosystems, Foster City, CA) as previously described [12,20,28].
Western blot analysis
Hearts from E14.5 embryos were harvested and used to prepare
protein extract. Three hearts from embryos with matching geno-
types were pooled. Protein extracts were run on PAGE-SDS gels
and transferred to PVDF membranes followed by incubation with
primary antibodies specific for Foxm1 (1:1000; C20; Santa Cruz),
Cyclin B1 (1:500; BD Pharmingen), or p21
cip1 (1:300; BD
Pharmingen). Secondary antibodies were conjugated with horse-
radish peroxidase. b-actin was used as a loading control.
Figure 1. Foxm1 expression during heart development. Foxm1 protein was evaluated in microtome sections of paraffin-embedded hearts
from embryonic day 14.5 (E14.5) (A, E, I, M), E17.5 (B, F, J, N), postnatal day 7 (P7) (C, G, K, O), and adult wild type mice (D, H, L, P) by
immunohistochemistry with Foxm1 antibodies [37] and counterstained with nuclear fast red (red nuclei). Foxm1 was detected in cardiomyocytes
(arrows) and endocardial cells (arrowheads) from the ventricles (E–H, M–P), interventricular septum (inset E–H), and atrial walls (I–L) throughout
cardiac development although expression progressively waned. Foxm1 was also detected in valves at E14.5 and E17.5 (inset I–J) but not postnatally
(inset K–L). Foxm1-positive nuclei were detected in the embryonic pericardium (inset M–N) and in the coronary vasculature (inset O–P) until P7. The
number of Foxm1-positive nuclei decreased during gestation in cardiomyocytes but was unaltered in endocardial cells (Q). Mean6SEM was
determined from 5 random sections at E14.5 and P7 with 3 hearts in each group. qRT-PCR of total heart RNA demonstrated a decrease in Foxm1
mRNA from E14.5 to P20 and Foxm1 mRNA was undetectable in the adult heart (R). Foxm1 expression was normalized to b-actin mRNA. Significant
differences (p,0.05) were indicated by asterisk. ‘‘N’’ values were represented by boxes inside or above bars. Scale bars represent 100 mm in A–D
insets, 200 mm in A–D, 50 mm in E–L (main and insets) and 10 mm in M–P (main and insets).
doi:10.1371/journal.pone.0022217.g001
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Student’s T-test was used to determine statistical significance. P
values ,0.05 were considered significant. Values for all measure-
ments were expressed as mean6standard error of mean (SEM).
Results
Foxm1 protein and mRNA expression declines during
embryonic and postnatal development
Hearts were collected from wild type mice at multiple
timepoints during cardiac development. To identify cells express-
ing Foxm1, microtome sections of paraffin-embedded hearts were
immunohistochemically stained using anti-Foxm1 antibodies.
Foxm1 protein was highly abundant in the embryonic period
and easily detectable in nuclei of cardiomyocytes and endothelial
cells up to postnatal day 7 (P7) (Figure 1A–H). Foxm1 staining was
observed throughout the developing heart, in the ventricles
(Figure 1E–H and M–P), interventricular septum (insets of
Figure 1E–H), atria (Figure 1I–L), heart valves (insets of
Figure 1I–L), pericardium (insets of Figure 1M–N) and vasculature
(insets of Figure 1O–P). The percentage of Foxm1-positive
cardiomyocytes decreased from 29% at E14.5 to 20% at P7
Figure 2. Generation of Nkx2.5-Cre/Foxm1
fl/fl mice and efficiency of Foxm1 deletion. The Cre-LoxP system was utilized to generate a mouse
line in which Foxm1 was selectively deleted from myocardial cells (A). Foxm1
fl/fl mice were crossed with mice expressing Nkx2.5-Cre to generate a
mouse line in which Foxm1 is truncated in cardiomyocytes early in embryonic development. Microtome sections of paraffin-embedded hearts were
prepared from Nkx2.5-Cre/Foxm1
fl/fl and control (Foxm1
fl/fl) mice at E14.5 (B–C, J–O), E17.5 (D–E) and P11 (F–G) and stained with Foxm1 antibodies.
Foxm1 was observed in myocardial (arrows) and endocardial (arrowheads) cells. Quantification of the percentage of Foxm1-positive nuclei showed
that cardiomyocytes positive for Foxm1 were significantly decreased in Nkx2.5-Cre/Foxm1
fl/fl hearts compared to control at E14.5 and E17.5 (H).
Similarly, Foxm1 mRNA was decreased in Nkx2.5-Cre/Foxm1
fl/fl hearts at E14.5 and E17.5 as determined by qRT-PCR (I). Foxm1 expression was
normalized to b-actin mRNA. Foxm1 was more readily detectable in cardiomyocytes from control (J–K, N) than Nkx2.5-Cre/Foxm1
fl/fl hearts (L–M, O) as
evidenced by colocalization of Foxm1-positive nuclei with a-actinin (N–O). However, Foxm1-positive endocardial cells could be detected in control (K)
and Nkx2.5-Cre/Foxm1
fl/fl hearts (M). Significant differences (p,0.05) were indicated by asterisk. ‘‘N’’ values were represented by boxes inside bars.
Scale bars represent 200 mm in B–G and 50 mm in J–O.
doi:10.1371/journal.pone.0022217.g002
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the adult heart as only 461% of cardiomyocytes were Foxm1-
positive (data not shown). In addition, hearts were used to isolate
total RNA and Foxm1 mRNA expression was examined by qRT-
PCR. Similar to Foxm1 protein expression, Foxm1 mRNA was
most highly expressed in the early embryonic period. Foxm1
expression declined by 30% from E14.5 to E17.5, but maintained
a similar level of expression until P2. Foxm1 mRNA levels
decreased rapidly in the postnatal period from P2 to P20, and
Foxm1 mRNA was undetectable in the adult heart (11 weeks)
(Figure 1R).
Cardiomyocyte-specific deletion of Foxm1 causes
embryonic lethality
Previous studies demonstrated that complete deletion of Foxm1
(Foxm1
2/2 mice) caused embryonic lethality between E13.5 and
E16.5 and presented with malformation of multiple organ systems
[25]. To ascertain the cardiomyocyte-autonomous role of Foxm1
signaling in cardiac development, Foxm1
fl/fl mice (in which LoxP
sites flank exons 4–7) were crossed with Nkx2.5-Cre mice to
generate a mouse line in which the DNA binding and
transcriptional activation domains of the Foxm1 protein were
excised in cardiomyocytes (Figure 2A). Breeding pairs between
Foxm1
fl/fl and Nkx2.5-Cre/Foxm1
fl/+ heterozygous mice were used
to generate embryos with the Nkx2.5-Cre transgene and homozy-
gous for the Foxm1
fl/fl allele (Nkx2.5-Cre/Foxm1
fl/fl) at an expected
ratio of 1:4. The majority of Nkx2.5-Cre/Foxm1
fl/fl embryos did not
survive to birth (Table 2). Although a near Mendelian ratio was
observed for Nkx2.5-Cre/Foxm1
fl/fl embryos at E14.5 (Table 2),
between E14.5 and E17.5 nearly 50% of Nkx2.5-Cre/Foxm1
fl/fl
embryos were lost, with the remaining 50% lost between E17.5
and birth (Table 2). Only one Nkx2.5-Cre/Foxm1
fl/fl pup survived
to postnatal day 11 but exhibited severe growth retardation prior
to harvest (data not shown). Thus, Foxm1 deletion from
cardiomyocytes is sufficient to induce embryonic lethality.
Efficiency of Foxm1 deletion from cardiomyocytes and
endocardial cells was determined by immunohistochemical
staining with antibodies against Foxm1. The percentage of
Foxm1-positive cardiomyocyte nuclei was significantly decreased
in Nkx2.5-Cre/Foxm1
fl/fl embryos compared to littermate controls
(Figure 2H). However, the percentage of Foxm1-positive endo-
cardial cells was unchanged (41.262.7% vs. 40.965.4% at E14.5
and 37.161.4% vs. 38.861.3% at E17.5 for Foxm1
fl/fl and Nkx2.5-
Cre/Foxm1
fl/fl respectively, Figure 2K and M, insets B–G),
indicating specificity of Foxm1 deletion to cardiomyocytes.
Cardiomyocyte Foxm1 staining was decreased by as much as
77% at E14.5 and was still decreased by nearly 63% at E17.5
(Figure 2H). The observed efficiency of Foxm1 deletion in Nkx2.5-
Cre/Foxm1
fl/fl hearts was substantiated by qRT-PCR analysis of
total heart RNA. Compared to Foxm1
fl/fl littermates, Foxm1
mRNA was decreased by 82% and 47% in Nkx2.5-Cre/Foxm1
fl/fl
hearts at E14.5 and E17.5, respectively (Figure 2I).
Embryonic deletion of Foxm1 from cardiomyocytes
causes myocardial thinning, ventricular hypoplasia and
disorganization of the myocardium
Hearts from Nkx2.5-Cre/Foxm1
fl/fl embryos exhibited abnormal
cardiac morphology in comparison to Foxm1
fl/fl and Nkx2.5-Cre/
Foxm1
fl/+ littermate controls. The ventricular lumen was dilated
and ventricular walls were thinner in Foxm1 deficient embryos
compared to control embryos (Figure 3A–L). Ventricular wall
thickness was significantly decreased at E14.5 and E17.5
(Figure 3E–L, Table 3). Thickness of the interventricular septum
(IVS) was decreased by 42% and 62% at E14.5 and E17.5,
respectively, (Figure 3M–P, Table 3) and cardiomyocyte organi-
zation within the IVS was in disarray (Figure 3M–P). There was,
however, no significant change in the overall size of the heart at
these two embryonic timepoints (Figure 3A–D). Furthermore,
although an increased network of extracellular matrix was
observed in valves from Nkx2.5-Cre/Foxm1
fl/fl mice, there was no
overall effect on valve size by deletion of Foxm1 from
cardiomyocytes (Figure 3Q–X). In addition, there were no gross
morphological changes in other organs known to delineate from
Nkx2.5 expressing cells such as the thymus (data not shown).
Decreased cardiomyocyte proliferation in Nkx2.5-Cre/
Foxm1
fl/fl embryos
Cardiac proliferation was examined in Nkx2.5-Cre/Foxm1
fl/fl and
control embryos by immunohistochemical staining with antibodies
against either phospho-histone 3 (PH3) or Ki-67. PH3-positive
cardiomyocytes undergoing mitosis were observed in both Nkx2.5-
Cre/Foxm1
fl/fl and control Foxm1
fl/fl mice at all timepoints studied
(Figure 4A–H). However, cardiomyocyte proliferation was signif-
icantly diminished in Nkx2.5-Cre/Foxm1
fl/fl hearts compared to
littermate controls as indicated by significant decreases in the
percentage of PH3-positive cardiomyocytes of 39% at E14.5 and
43% at E17.5 (Figure 4I). Yet, there was no change in cellular
proliferation within the lung or in endocardial cells at these same
timepoints (Figure 4I), indicating that proliferation defects were
restricted to cardiomyocytes in Nkx2.5-Cre/Foxm1
fl/fl embryos.
Consistent with decreased numbers of PH3-positive cardiomyo-
cytes, Nkx2.5-Cre/Foxm1
fl/fl hearts displayed a dramatic reduction
in Ki-67, a proliferation-specific protein (Figure 4C–D). Further-
more, decreased mRNA expression of cell cycle regulators
Cdc25B, Cyclin B1, Polo-like kinase 1 (Plk-1) and nMyc was
found in E14.5 Nkx2.5-Cre/Foxm1
fl/fl hearts by qRT-PCR
(Figure 4M). There was no change in the expression of Cyclin
D1 or cMyc (Figure 4M). In addition, Nkx2.5-Cre/Foxm1
fl/fl hearts
displayed increased mRNA levels of p21
cip1 (Figure 4M), a known
cell cycle inhibitor critical for activity of cyclin-dependent kinase 2
(cdk2). Western blot analysis confirmed decreased protein levels of
Foxm1 and Cyclin B1 as well as increased p21
cip1 expression in
Nkx2.5-Cre/Foxm1
fl/fl hearts (Figure 4L). These results demonstrat-
ed that Foxm1 deletion from cardiomyocytes altered expression of
cell cycle regulatory genes, contributing to proliferation defects
and structural abnormalities in the developing heart.
Decreased capillary density and cardiac fibrosis in
postnatal Nkx2.5-Cre/Foxm1
fl/fl hearts
Microtome sections of paraffin-embedded hearts from Nkx2.5-
Cre/Foxm1
fl/fl and control mice were subjected to immunohisto-
Table 2. Breeding table Nkx2.5-Cre/Foxm1
fl/+ X Foxm1
fl/fl.
E14.5 E17.5 Newborns
Total embryos/pups 31 46 67
Expected ratio of Nkx2.5-Cre/Foxm1
fl/fl 0.25 0.25 0.25
Experimental ratio of Nkx2.5-Cre/Foxm1
fl/fl 0.23 0.13 0.01
% lethality of Nkx2.5-Cre/Foxm1
fl/fl 9.68 47.83 94.03
Cumulative breeding data between Nkx2.5-Cre/Foxm1
fl/+ and Foxm1
fl/fl mice
shows significant lethality in Nkx2.5-Cre/Foxm1
fl/fl embryos by day 17.5 (E17.5).
47% of Nkx2.5-Cre/Foxm1
fl/fl embryos died by E17.5 and 94% lethality was
observed in Nkx2.5-Cre/Foxm1
fl/fl embryos at birth.
doi:10.1371/journal.pone.0022217.t002
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muscle actin (aSM). PECAM-1 staining indicated a clear paucity
in capillary density in the Nkx2.5-Cre/Foxm1
fl/fl mouse heart at P11
(Figure 5A–B). Subsequent quantification showed a greater than
50% decrease in capillary density in the Nkx2.5-Cre/Foxm1
fl/fl heart
compared to Foxm1
fl/fl control at P11 (Figure 5I). Despite the
decreased capillary density, there was no difference in the number
or morphology of coronary vessels in Nkx2.5-Cre/Foxm1
fl/fl mouse
Figure 3. Myocardial thinning and cardiomyocyte disarray in Nkx2.5-Cre/Foxm1
fl/fl mice. Microtome sections of paraffin-embedded hearts
were prepared from Nkx2.5-Cre/Foxm1
fl/fl and control Foxm1
fl/fl mice at E14.5 and E17.5 and stained with hematoxylin and eosin (H&E). H&E staining
showed that hearts from Nkx2.5-Cre/Foxm1
fl/fl embryos possessed all four chambers and were similar in size to littermate control hearts (A–D).
However, there was thinning of the muscular wall of the right ventricle (RV) (E–H), left ventricle (LV) (I–L), and interventricular septum (IVS) (M–P)i n
addition to disorganization of the musculature. There was no difference in the size of the leaflets in either the mitral (MV) (Q–T) or tricuspid valves
(TV) (U–X). Arrowheads indicate area where measurements of thickness were made. Scale bars represent 100 mm in A–B and E–P, 200 mm in C–D and
50 mm in Q–X.
doi:10.1371/journal.pone.0022217.g003
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microtome sections from Nkx2.5-Cre/Foxm1
fl/fl hearts were stained
with Masson’s Trichrome to detect cardiac fibrosis. Although
there were no obvious signs of cardiac fibrosis at E17.5 (data not
shown), the postnatal Nkx2.5-Cre/Foxm1
fl/fl mouse heart displayed
extensive fibrotic depositions in the interventricular septum as well
as the apex of the ventricles (Figure 5F and H). No fibrosis was
observed in postnatal Foxm1
fl/fl control hearts (Figure 5E and G).
Thus, Foxm1 deletion from cardiomyocytes altered vascular
organization and induced cardiac fibrosis.
Foxm1 deletion from cardiomyocytes caused decreased
expression of CaMKIId, NFATc3, myocardin and Hey2
To determine new potential Foxm1 target genes in the
developing heart, expression of transcription factors and signaling
molecules critical for heart morphogenesis or Foxm1 signaling was
examined by qRT-PCR. Nkx2.5-Cre/Foxm1
fl/fl embryos displayed
a significant decrease in cardiac expression of NFATc3 (Figure 6A),
a known Foxm1 target gene [13]. These results are consistent with
reduced expression of NFATc3 in Foxm1-depleted ML-1 cells and
hearts from Foxm1
2/2 mice [13]. Embryonic Nkx2.5-Cre/Foxm1
fl/fl
hearts exhibited normal mRNA expression of the intracellular
signaling molecule b-catenin and the transcription factors
GATA4, GATA6, Twist1, Twist2 and Sox4 (Figure 6A–B).
Although interleukin-1b mRNA was increased in Nkx2.5-Cre/
Foxm1
fl/fl hearts (Figure 6C), there was no change in mRNA levels
of other extracellular signaling molecules critical for heart
morphogenesis, such as Notch1, Notch4, FGF10, TGF-b1,
BMP2, BMP4, Wnt 5a or Wnt 7b (Figure 6C–D).
Expression of calcium/calmodulin-dependent kinase IId (CaM-
KIId) was significantly reduced in Nkx2.5-Cre/Foxm1
fl/fl hearts
(Figure 6A). CaMKIId is an intracellular signaling molecule that is
known to play a critical role in beat-to-beat cardiac physiology and
has been shown to be an essential mediator of pressure overload
and pharmacologically induced hypertrophy [37]. In addition,
CaMKIId mediates calcium signaling and growth mechanisms
within the cardiomyocyte [38]. Our results suggest that CaMKIId
is a downstream effector of Foxm1 signaling as well as a
contributing factor in myocardial thinning and embryonic lethality
associated with cardiomyocyte-specific Foxm1 deletion.
Expression of both Hey2 and myocardin was reduced in Nkx2.5-
Cre/Foxm1
fl/fl hearts (Figure 6B). Hey2 knockout mice exhibited a
thin walled left ventricle and decreased cardiomyocyte prolifera-
tion [8], similar to the phenotype in Nkx2.5-Cre/Foxm1
fl/fl mice.
Myocardin is a cofactor for the serum response factor (SRF) and is
essential for cardiogenesis [39,40]. Furthermore, SRF knockout
mice exhibited a thin myocardium with dilated chambers and
disorganized IVS [41], a phenotype similar to Nkx2.5-Cre/Foxm1
fl/
fl hearts. Therefore, decreased expression of Hey2 and myocardin
may contribute to the cardiac abnormalities and embryonic
lethality of the Nkx2.5-Cre/Foxm1
fl/fl mouse. Altogether, our results
demonstrate that Foxm1 deletion from cardiomyocytes alters
expression of cardiac genes critical for heart morphogenesis and
cardiomyocyte proliferation.
Discussion
We have previously generated and characterized a Foxm1-null
(Foxm1
2/2) mouse line in which mice die between embryonic days
E13.5 and E16.5 due to severe defects in multiple organ systems
including lungs, liver, heart and blood vessels [25]. We further
demonstrated that tissue-specific deletion of Foxm1 from hepato-
cytes [25], respiratory epithelium [12] or smooth muscle cells [28]
was sufficient to cause lethality in utero or shortly after birth.
Therefore, Foxm1 is essential for organ morphogenesis in multiple
organ systems. However, it remained to be determined whether
cardiac malformation in Foxm1
2/2 embryos was due to cardio-
myocyte derived effects of Foxm1 signaling or if these Foxm1
2/2
defects were indirect, resulting from abnormalities in other organ
systems and altered embryonic homeostasis. To elucidate the
cardiomyocyte-autonomous role of Foxm1 in embryonic heart
development, we used the Cre-LoxP system to generate a
conditional Foxm1 knockout mouse line in which Foxm1 is
selectively deleted from cardiomyocytes under control of the
Nkx2.5 promoter, one of the earliest known cardiac markers.
Deletion of Foxm1 from cardiomyocytes caused thinning and
disorganization of the muscular walls of the heart, including both
ventricles and the interventricular septum. Myocardial thinning
was due to decreased cardiomyocyte proliferation accompanied by
altered expression of multiple cell cycle regulatory genes.
Ultimately, the myocardial hypoplasia in Nkx2.5-Cre/Foxm1
fl/fl
embryos caused lethality in late gestation. Although the myocar-
dial phenotype exhibited similarities to that observed in hearts
from Foxm1
2/2 mice, many unique features were observed in the
conditional knockout model suggesting cardiomyocyte-autono-
mous roles for Foxm1 signaling. These include a delay in the onset
of lethality, unaltered heart size, diminished cardiac capillary
density and myocardial fibrosis. The decrease in cardiomyocyte
proliferation in Nkx2.5-Cre/Foxm1
fl/fl embryos was significantly less
than in Foxm1
2/2 embryos suggesting that abnormalities in other
cell types or tissues contributed to cardiac malformation in mice
with complete deletion of Foxm1. Although we observed increased
deposition of extracellular matrix in the atrio-ventricular valves of
Nkx2.5-Cre/Foxm1
fl/fl hearts the size of the valves was unaltered.
These results are in contrast to valve thickening in Foxm1
2/2 mice
[13] and suggest that although Foxm1 does mediate atrio-
ventricular valve formation, this signaling is not cardiomyocyte-
dependent. Alternatively, valve defects Foxm1
2/2 mice may result
from altered blood pressure caused by structural abnormalities in
blood vessels that were previously reported [26].
Table 3. Cardiac morphologic parameters.
E14.5 E17.5
RV (mm) LV (mm) IVS (mm) RV (mm) LV (mm) IVS (mm)
Foxm1
fl/fl 75.365.0 104.269.7 222.9623.8 172.365.2 143.465.5 369.5620.0
Nkx2.5- Cre/Foxm1
fl/fl 63.068.4 59.665.1* 142.2624.2* 98.564.4* 94.667.4* 159.1612.6*
Hearts from Nkx2.5-Cre/Foxm1
fl/fl embryos had significantly decreased myocardial thickness compared to littermate control mice at E14.5 and E17.5. Five sections from 3
Foxm1
fl/fl and Nkx2.5-Cre/Foxm1
fl/fl embryos were measured to calculate mean6SEM. Significant differences (p,0.05) shown with asterisks. Abbreviations: RV, right
ventricle; LV, left ventricle; IVS, interventricular septum.
doi:10.1371/journal.pone.0022217.t003
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PLoS ONE | www.plosone.org 7 July 2011 | Volume 6 | Issue 7 | e22217Figure 4. Decreased cardiomyocyte proliferation in Nkx2.5-Cre/Foxm1
fl/fl hearts. Microtome sections of paraffin-embedded hearts were
prepared from Nkx2.5-Cre/Foxm1
fl/fl and control mice at E14.5 (A–D, J–K), E17.5 (E–F) and P11 (G–H) and stained for proliferation markers phospho-
histone 3 (PH3) (A–B, E–H, J–K) and Ki-67 (C–D). The percent of PH3-positive cardiomyocytes was significantly lower in Nkx2.5-Cre/Foxm1
fl/fl hearts
compared to control at E14.5 and E17.5, though proliferation was unaltered in the lung and in endocardial cells (I). Proliferating cardiomyocytes were
more prevalent in control (J) than in Nkx2.5-Cre/Foxm1
fl/fl hearts (K) as evidenced by colocalization of PH3-positive nuclei with a-actinin. Consistent
with decreased proliferation in Nkx2.5-Cre/Foxm1
fl/fl hearts, there was decreased mRNA expression of the cell cycle regulators Cdc25B, Cyclin B1, Plk-1
and nMyc as determined by qRT-PCR (M). There was no change in the expression of Cyclin D1 or cMyc. Also consistent with decreased proliferation,
there was increased mRNA expression of the cell cycle inhibitor p21
cip1. Gene expression was determined using whole heart RNA and normalized to
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PLoS ONE | www.plosone.org 8 July 2011 | Volume 6 | Issue 7 | e22217To date, embryonic lethality associated with ventricular
hypoplasia and myocardial thinning has been linked to several
signaling cascades including the transcription factor Hey2 [8],
members of the NFAT family [42] or inactivation of serum
response factor (SRF) [41]. In this study we described a model of
myocardial thinning owing to multiple factors and resulting in
embryonic lethality. In addition to altered expression of various
cell cycle regulatory genes, this study identified Hey2, myocardin
and CaMKIId as novel targets of Foxm1 signaling in vivo and as
potential mediators of the thin ventricular phenotype.
We previously showed decreased expression of NFATc3 in
Foxm1
2/2 hearts and in Foxm1-depleted cardiomyocytes in vitro
[13]. This study confirmed that Foxm1 is a positive regulator of
cardiac NFATc3 expression and further identified cardiomyocytes
as the cell type responsible for Foxm1-regulated NFATc3
expression in vivo. It has been previously shown that dual deletion
of NFATc3 and NFATc4 causes thin ventricles, decreased
proliferation of ventricular myocytes and pericardial effusion
culminating in embryonic lethality [42]. Therefore, decreased
NFATc3 expression could be a contributing factor in myocardial
thinning and embryonic lethality associated with Nkx2.5-Cre/
Foxm1
fl/fl mice.
Decreased expression of Hey2 can contribute to the cardiac
phenotype and embryonic lethality of Nkx2.5-Cre/Foxm1
fl/fl mice
as evidenced by embryonic lethality and myocardial thinning in
Hey2
2/2 mice, a phenotype similar to Nkx2.5-Cre/Foxm1
fl/fl mice.
Hey2 has also been shown to interact with the serum response
factor (SRF) to inhibit activity of myocardin [43], which is essential
for cardiogenesis, cardiomyocyte proliferation, migration and
deposition of the extracellular matrix [39,44,45]. Furthermore,
deletion of SRF from cardiomyocytes resulted in lethality between
E10.5–13.5 with thin myocardium, dilated chambers and
disorganized IVS [41], a phenotype similar to that observed in
the Nkx2.5-Cre/Foxm1
fl/fl hearts. Therefore, Foxm1 may directly
influence myocardial development by decreasing expression of
Hey2 and myocardin and possibly interfering with SRF-mediated
signaling in cardiomyocytes.
CaMKIId deficiency caused augmented cardiac function in
multiple heart injury models which manifested as severe
alterations in cardiac structure. The finding of decreased
CaMKIId mRNA in Nkx2.5-Cre/Foxm1
fl/fl hearts suggests a role
for Foxm1 in regulating cardiac CaMKIId expression. Interest-
ingly, interleukin-1b (IL-1b) mRNA was increased in Nkx2.5-Cre/
Foxm1
fl/fl hearts. IL-1b has been reported to be a critical mediator
of cardiac fibrosis [46]. Since significant fibrosis was observed in
the postnatal Nkx2.5-Cre/Foxm1
fl/fl heart, increased expression of
IL-1b may contribute to fibrotic deposition.
In summary, we demonstrated that Foxm1 plays a cell-
autonomous role in cardiomyocytes during cardiac development.
Foxm1 deletion in developing cardiomyocytes caused embryonic
lethality, decreased cardiomyocyte proliferation, diminished vas-
cular density in the myocardium and induced cardiac fibrosis in
the early postnatal period. This study further identified Hey2,
myocardin, NFATc3, CaMKIId and various cell cycle regulatory
genes as in vivo targets of Foxm1 signaling and potential mediators
of the myocardial thinning and ventricular hypoplasia associated
with the Nkx2.5-Cre/Foxm1
fl/fl phenotype.
Figure 5. Decreased capillary density and cardiac fibrosis in
Nkx2.5-Cre/Foxm1
fl/fl heart. Microtome sections of paraffin-embedded
hearts were prepared from either Nkx2.5-Cre/Foxm1
fl/fl or littermate
control mice at P11 and stained for PECAM-1 (A–B), a-smooth muscle
actin (aSM) (C–D) or Masson’s Trichrome (E–H). Capillary density was
decreased in Nkx2.5-Cre/Foxm1
fl/fl hearts at P11 (A–B, I), while coronary
vessel formation was not altered (C–D). Numbers of capillaries were
counted in PECAM-stained hearts using 10 random sections and
mean6SEM was determined to confirm decreased capillary density (I).
Significant fibrosis was detected in the IVS and ventricular walls of
Nkx2.5-Cre/Foxm1
fl/fl hearts (F, H) while none was detected in control
hearts (E, G). Significant differences (p,0.05) were indicated by asterisk.
Scale bars represent 100 mm in A–F and 50 mm in G–H.
doi:10.1371/journal.pone.0022217.g005
b-actin mRNA. Decreased gene expression of Foxm1, Cyclin B1, and increased p21
cip1 expression translated to changes in protein levels as
demonstrated by Western blot analysis (L). b-actin was used as a loading control. Significant differences (p,0.05) were indicated by asterisk. ‘‘N’’
values were represented by boxes inside bars. Scale bars represent 50 mm in A–H and J–K and 10 mm in insets E–H.
doi:10.1371/journal.pone.0022217.g004
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